Gene Therapy for the Treatment of Parkinson’s Disease: The Nature of the Biologics Expands the Future Indications

Author： Fiandaca Massimo S. Bankiewicz Krystof S. Federoff Howard J.

Publisher： MDPI

E-ISSN： 1424-8247|5|6|553-590

ISSN： 1424-8247

Source： Pharmaceuticals, Vol.5, Iss.6, 2012-06, pp. : 553-590

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Protein Kinases and Parkinson’s Disease

By Mehdi Syed Jafar Rosas-Hernandez Hector Cuevas Elvis Lantz Susan M. Barger Steven W. Sarkar Sumit Paule Merle G. Ali Syed F. Imam Syed Z.

International Journal of Molecular Sciences, Vol. 17, Iss. 9, 2016-09 ,pp. : 1585-1585

MDPI

Access to resources Recommend Favorite

Analysis of Epidermal Growth Factor Receptor Related Gene Expression Changes in a Cellular and Animal Model of Parkinson’s Disease

By Kim In-Su Koppula Sushruta Park Shin-Young Choi Dong-Kug

International Journal of Molecular Sciences, Vol. 18, Iss. 2, 2017-02 ,pp. : 430-430

MDPI

Access to resources Recommend Favorite

The Yin and Yang of VEGF and PEDF: Multifaceted Neurotrophic Factors and Their Potential in the Treatment of Parkinson’s Disease

By Falk Torsten Gonzalez Robert T. Sherman Scott J.

International Journal of Molecular Sciences, Vol. 11, Iss. 8, 2010-08 ,pp. : 2875-2900

MDPI

Access to resources Recommend Favorite

Mitochondria: A Therapeutic Target for Parkinson’s Disease?

By Luo Yu Hoffer Alan Hoffer Barry Qi Xin

International Journal of Molecular Sciences, Vol. 16, Iss. 9, 2015-09 ,pp. : 20704-20730

MDPI

Access to resources Recommend Favorite

Roles of PTEN with DNA Repair in Parkinson’s Disease

By Ogino Mako Ichimura Mayuko Nakano Noriko Minami Akari Kitagishi Yasuko Matsuda Satoru

International Journal of Molecular Sciences, Vol. 17, Iss. 6, 2016-06 ,pp. : 954-954

MDPI

Access to resources Recommend Favorite